KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Share-based Compensation (2020 - 2025)

Oscar Health (OSCR) has disclosed Share-based Compensation for 6 consecutive years, with $18.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 30.05% year-over-year to $18.1 million, compared with a TTM value of $87.7 million through Dec 2025, down 20.19%, and an annual FY2025 reading of $87.7 million, down 20.19% over the prior year.
  • Share-based Compensation was $18.1 million for Q4 2025 at Oscar Health, down from $20.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $71.5 million in Q1 2023 and bottomed at $18.1 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $27.8 million, with a median of $26.6 million recorded in 2022.
  • The sharpest move saw Share-based Compensation skyrocketed 183.24% in 2021, then tumbled 63.71% in 2024.
  • Year by year, Share-based Compensation stood at $28.3 million in 2021, then grew by 2.9% to $29.1 million in 2022, then decreased by 10.13% to $26.1 million in 2023, then fell by 1.1% to $25.9 million in 2024, then tumbled by 30.05% to $18.1 million in 2025.
  • Business Quant data shows Share-based Compensation for OSCR at $18.1 million in Q4 2025, $20.5 million in Q3 2025, and $24.1 million in Q2 2025.